Centinel Spine has announced that it has initiated US Alpha Site evaluation of the Stalif C No Profile Stand Alone Cervical Intervertebral Body Fusion (IBF) device for single level use in the treatment of cervical degenerative disc disease. The company expects Stalif C to be available in early 2009, enabling spine surgeons to use the technology as an IBF device without supplementary fixation.
This evaluation is expected to take from one to two months and will determine when Centinel Spine will initiate the US sales launch of the Stalif C device in 2009.
“The Alpha Site evaluation of the Stalif C is an important step of many steps needed for bringing this unique device to the US spine fusion market,” said John J Viscogliosi, chairman and CEO of Centinel Spine.
